BMP-2 and VEGF-A modRNAs in collagen scaffold synergistically drive bone repair through osteogenic and angiogenic pathways
Open Access
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Communications Biology
- Vol. 4 (1), 1-14
- https://doi.org/10.1038/s42003-020-01606-9
Abstract
Bone has a remarkable potential for self-healing and repair, yet several injury types are non-healing even after surgical or non-surgical treatment. Regenerative therapies that induce bone repair or improve the rate of recovery are being intensely investigated. Here, we probed the potential of bone marrow stem cells (BMSCs) engineered with chemically modified mRNAs (modRNA) encoding the hBMP-2 and VEGF-A gene to therapeutically heal bone. Induction of osteogenesis from modRNA-treated BMSCs was confirmed by expression profiles of osteogenic related markers and the presence of mineralization deposits. To test for therapeutic efficacy, a collagen scaffold inoculated with modRNA-treated BMSCs was explored in an in vivo skull defect model. We show that hBMP-2 and VEGF-A modRNAs synergistically drive osteogenic and angiogenic programs resulting in superior healing properties. This study exploits chemically modified mRNAs, together with biomaterials, as a potential approach for the clinical treatment of bone injury and defects.Keywords
This publication has 62 references indexed in Scilit:
- Driving vascular endothelial cell fate of human multipotent Isl1+ heart progenitors with VEGF modified mRNACell Research, 2013
- Nonviral gene transfer strategies to promote bone regenerationJournal of Biomedical Materials Research Part A, 2013
- A Comparative Analysis of the Osteogenic Effects of BMP-2, FGF-2, and VEGFA in a Calvarial Defect ModelTissue Engineering, Part A, 2012
- Increased Erythropoiesis in Mice Injected With Submicrogram Quantities of Pseudouridine-containing mRNA Encoding ErythropoietinMolecular Therapy, 2012
- The potential of human fetal mesenchymal stem cells for off-the-shelf bone tissue engineering applicationBiomaterials, 2012
- A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learnedThe Spine Journal, 2011
- Expression of therapeutic proteins after delivery of chemically modified mRNA in miceNature Biotechnology, 2011
- Phases 1–3 Clinical Trials Using Adult Stem Cells in Osteonecrosis and Nonunion FracturesStem Cells International, 2010
- Superior Osteogenic Capacity for Bone Tissue Engineering of Fetal Compared with Perinatal and Adult Mesenchymal Stem CellsThe International Journal of Cell Cloning, 2009
- Recombinant human VEGF165b protein is an effective anti-cancer agent in miceEuropean Journal of Cancer, 2008